Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07816809 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phage-based Control and Limitation of Pathobionts for Microbiome Equilibrium and Resilience

Study acronym: Phage-CLEAR
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fields
  2. Study First Submitted
Bacteriophages are viruses that can selectively infect specific species and strains of bacteria. Some bacterial species in the human gut have been negatively associated with gut health and skin health. This study is designed to measure the efficacy of two different bacteriophage-based treatments for 4 weeks to improve gut and skin health. These treatments are bacteriophage that target specific strains of Escherichia coli and Staphylococcus Aureus.
Trial Details
NCT Number NCT07816809
Lead Sponsor Colorado State University
Conditions
(from sponsor)		 Gastrointestinal Symptoms, Skin Quality
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov